United States Healthcare Equipment & Supplies

Tactile Systems Technology Inc (TCMD)

Track

Tactile Systems Technology Inc. experienced notable insider trading activity earlier this year. The most recent transactions occurred on May 11, 2026, involving a sale by the Chief Financial Officer. Prior to this, several executives executed multiple sell orders throughout February 2026, reflecting a period of divestment by key leadership members within the organization.
Ticker: TCMD Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Tactile Systems Technology Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 10 Aug 2026
Value US$2,597,312.46 | Price 15.25 | Shares 78,902
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-10 2026-08-10 PrS Proposed sale
2.9
Dodd Sheri Louise

Officer; Director

Executive Director
78,902
15.25
US$2,597,312 		78,902 15.25 US$2,597,312
2026-05-13 2026-05-11 S Sale
3.3
Birkemeyer Elaine M.

CHIEF FINANCIAL OFFICER

Officer
69,408 -23.6%
391.03
US$4,055,927 		69,408 -23.6% 391.03 US$4,055,927
2026-05-11 2026-05-11 PrS Proposed sale
3.3
Birkemeyer Elaine M.

Officer

Officer
93,309
224.08
US$4,641,710 		93,309 224.08 US$4,641,710
2026-02-25 2026-02-25 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
4,000
28.47
US$113,880 		4,000 28.47 US$113,880
2026-02-26 2026-02-24 S Sale
2.9
Dodd Sheri Louise

Chief Executive Officer

Executive Director
10,993 -4.3%
28.94
US$318,144 		10,993 -4.3% 28.94 US$318,144
2026-02-26 2026-02-24 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
6,246 -7.0%
28.94
US$180,764 		6,246 -7.0% 28.94 US$180,764
2026-02-26 2026-02-24 S Sale
3.3
Birkemeyer Elaine M.

CHIEF FINANCIAL OFFICER

Officer
7,701 -5.4%
28.94
US$222,880 		7,701 -5.4% 28.94 US$222,880
2026-02-24 2026-02-24 PrS Proposed sale
2.9
Dodd Sheri Louise

Officer; Director

Executive Director
10,993
28.94
US$318,148 		10,993 28.94 US$318,148
2026-02-24 2026-02-24 PrS Proposed sale
3.3
Birkemeyer Elaine M.

Officer

Officer
7,701
28.94
US$222,875 		7,701 28.94 US$222,875
2026-02-24 2026-02-24 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
6,246
28.94
US$180,765 		6,246 28.94 US$180,765
2026-02-24 2026-02-23 S Sale
3.3
Birkemeyer Elaine M.

CHIEF FINANCIAL OFFICER

Officer
196 -0.1%
28.69
US$5,623 		196 -0.1% 28.69 US$5,623
2026-02-24 2026-02-23 S Sale
3.3
Birkemeyer Elaine M.

CHIEF FINANCIAL OFFICER

Officer
5,322 -3.6%
28.28
US$150,521 		5,322 -3.6% 28.28 US$150,521
2026-02-24 2026-02-23 S Sale
2.9
Dodd Sheri Louise

Chief Executive Officer

Executive Director
537 -0.2%
28.69
US$15,406 		537 -0.2% 28.69 US$15,406
2026-02-24 2026-02-23 S Sale
2.9
Dodd Sheri Louise

Chief Executive Officer

Executive Director
14,703 -5.4%
28.28
US$415,839 		14,703 -5.4% 28.28 US$415,839
2026-02-24 2026-02-23 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
160 -0.2%
28.69
US$4,590 		160 -0.2% 28.69 US$4,590
2026-02-24 2026-02-23 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
4,279 -4.6%
28.28
US$121,022 		4,279 -4.6% 28.28 US$121,022
2026-02-23 2026-02-23 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
4,439
28.30
US$125,610 		4,439 28.30 US$125,610
2026-02-23 2026-02-23 PrS Proposed sale
2.9
Dodd Sheri Louise

Officer; Director

Executive Director
15,240
28.30
US$431,246 		15,240 28.30 US$431,246
2026-02-23 2026-02-23 PrS Proposed sale
3.3
Birkemeyer Elaine M.

Officer

Officer
5,518
28.30
US$156,143 		5,518 28.30 US$156,143
2026-01-06 2026-01-02 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
5,139 -6.6%
28.85
US$148,260 		5,139 -6.6% 28.85 US$148,260
2026-01-02 2026-01-02 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
5,139
28.85
US$148,260 		5,139 28.85 US$148,260
2025-08-12 2025-08-08 S Sale
2.9
Dodd Sheri Louise

Chief Executive Officer

Executive Director
7,762 -4.3%
12.36
US$95,907 		7,762 -4.3% 12.36 US$95,907
2025-08-08 2025-08-08 PrS Proposed sale
2.9
Dodd Sheri Louise

Officer; Director

Executive Director
7,762
12.36
US$95,906 		7,762 12.36 US$95,906
2025-05-14 2025-05-12 PlS Planned sale
3.3
Birkemeyer Elaine M.

Chief Financial Officer

Officer
2,921 -2.9%
9.94
US$29,037 		2,921 -2.9% 9.94 US$29,037
2025-05-12 2025-05-12 PrS Proposed sale
3.3
Birkemeyer Elaine M.

Officer

Officer
2,921
9.94
US$29,037 		2,921 9.94 US$29,037
2025-05-12 2025-05-08 S Sale
2.9
Dodd Sheri Louise

Chief Executive Officer

Executive Director
3,149 -1.7%
9.83
US$30,955 		3,149 -1.7% 9.83 US$30,955
2025-05-09 2025-05-08 PlS Planned sale
2.6
BURKE WILLIAM W
Non-Executive Director
3,300 -6.4%
9.67
US$31,911 		3,300 -6.4% 9.67 US$31,911
2025-05-08 2025-05-08 PrS Proposed sale
2.9
Dodd Sheri Louise

Director

Non-Executive Director
3,149
9.83
US$30,955 		3,149 9.83 US$30,955
2025-05-08 2025-05-08 PrS Proposed sale
2.6
BURKE WILLIAM W

Director

Non-Executive Director
3,300
9.67
US$31,911 		3,300 9.67 US$31,911
2025-04-03 2025-04-03 PrS Proposed sale
0.8
Ferstler Sherri Lee

Officer

Officer
2,355
13.14
US$30,945 		2,355 13.14 US$30,945
2025-02-27 2025-02-25 PlS Planned sale
3.6
REUVERS DANIEL L.
Non-Executive Director
28,338 -11.7%
14.18
US$401,850 		28,338 -11.7% 14.18 US$401,850
2025-02-27 2025-02-25 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
6,468 -7.7%
14.40
US$93,160 		6,468 -7.7% 14.40 US$93,160
2025-02-27 2025-02-25 PlS Planned sale
3.3
Birkemeyer Elaine M.

Chief Financial Officer

Officer
2,066 -2.0%
14.51
US$29,980 		2,066 -2.0% 14.51 US$29,980
2025-02-25 2025-02-25 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
28,338
14.18
US$401,851 		28,338 14.18 US$401,851
2025-02-25 2025-02-25 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
6,468
14.40
US$93,160 		6,468 14.40 US$93,160
2025-02-25 2025-02-25 PrS Proposed sale
3.3
Birkemeyer Elaine M.

Officer

Officer
2,066
14.51
US$29,980 		2,066 14.51 US$29,980
2025-02-24 2025-02-24 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
10,938
14.55
US$159,147 		10,938 14.55 US$159,147
2025-02-24 2025-02-24 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
4,830
14.65
US$70,753 		4,830 14.65 US$70,753
2025-02-24 2025-02-24 PrS Proposed sale
0.8
Ferstler Sherri Lee

Officer

Officer
2,209
14.79
US$32,660 		2,209 14.79 US$32,660
2025-02-24 2025-02-24 PrS Proposed sale
3.3
Birkemeyer Elaine M.

Officer

Officer
3,778
14.70
US$55,538 		3,778 14.70 US$55,538
2025-02-24 2025-02-24 PlS Planned sale
3.6
REUVERS DANIEL L.
Non-Executive Director
10,938 -4.3%
14.55
US$159,147 		10,938 -4.3% 14.55 US$159,147
2025-02-24 2025-02-24 PlS Planned sale
3.3
Birkemeyer Elaine M.

Chief Financial Officer

Officer
3,778 -3.5%
14.70
US$55,538 		3,778 -3.5% 14.70 US$55,538
2025-02-24 2025-02-24 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
4,830 -5.4%
14.65
US$70,753 		4,830 -5.4% 14.65 US$70,753
2024-08-14 2024-08-12 S Sale
0.8
Ferstler Sherri Lee

Senior VP, Sales

Officer
1,550 -3.8%
13.07
US$20,263 		1,550 -3.8% 13.07 US$20,263
2024-08-12 2024-08-12 PrS Proposed sale
0.8
Ferstler Sherri Lee

Officer

Officer
1,550
13.07
US$20,262 		1,550 13.07 US$20,262
2024-05-20 2024-05-16 S Sale
3.3
Birkemeyer Elaine M.

Chief Financial Officer

Officer
3,041 -4.7%
13.68
US$41,590 		3,041 -4.7% 13.68 US$41,590
2024-05-16 2024-05-16 PrS Proposed sale
3.3
Birkemeyer Elaine M.

Officer

Officer
3,041
13.68
US$41,590 		3,041 13.68 US$41,590
2024-05-10 2024-05-08 PlS Planned sale
2.6
BURKE WILLIAM W
Non-Executive Director
2,500 -9.0%
14.06
US$35,150 		2,500 -9.0% 14.06 US$35,150
2024-05-08 2024-05-08 PrS Proposed sale
2.6
BURKE WILLIAM W

Director

Non-Executive Director
2,500
14.06
US$35,150 		2,500 14.06 US$35,150
2024-05-08 2024-05-06 S Sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
815 -1.3%
14.37
US$11,713 		815 -1.3% 14.37 US$11,713
2024-05-06 2024-05-06 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
815
14.37
US$11,713 		815 14.37 US$11,713
2024-02-29 2024-02-29 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
1,396
15.25
US$21,289 		1,396 15.25 US$21,289
2024-02-29 2024-02-29 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
243
15.25
US$3,706 		243 15.25 US$3,706
2024-02-29 2024-02-29 PlS Planned sale
3.6
REUVERS DANIEL L.

President and CEO

Executive Director
1,396 -0.6%
15.25
US$21,289 		1,396 -0.6% 15.25 US$21,289
2024-02-29 2024-02-29 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
243 -0.4%
15.25
US$3,706 		243 -0.4% 15.25 US$3,706
2024-02-29 2024-02-27 PlS Planned sale
3.6
REUVERS DANIEL L.

President and CEO

Executive Director
4,689 -1.9%
15.60
US$73,148 		4,689 -1.9% 15.60 US$73,148
2024-02-29 2024-02-27 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
1,091 -1.7%
15.58
US$17,001 		1,091 -1.7% 15.58 US$17,001
2024-02-27 2024-02-27 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
4,689
15.60
US$73,148 		4,689 15.60 US$73,148
2024-02-27 2024-02-27 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
1,091
15.58
US$17,001 		1,091 15.58 US$17,001
2024-02-27 2024-02-26 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
2,015 -3.1%
15.91
US$32,049 		2,015 -3.1% 15.91 US$32,049
2024-02-27 2024-02-26 PlS Planned sale
3.6
REUVERS DANIEL L.

President and CEO

Executive Director
6,239 -2.5%
15.81
US$98,645 		6,239 -2.5% 15.81 US$98,645
2024-02-26 2024-02-26 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
6,239
15.81
US$98,645 		6,239 15.81 US$98,645
2024-02-26 2024-02-26 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
2,015
15.91
US$32,049 		2,015 15.91 US$32,049
2024-02-27 2024-02-23 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
2,249 -4.0%
14.80
US$33,278 		2,249 -4.0% 14.80 US$33,278
2024-02-27 2024-02-23 PlS Planned sale
3.6
REUVERS DANIEL L.

President and CEO

Executive Director
5,378 -2.7%
14.85
US$79,853 		5,378 -2.7% 14.85 US$79,853
2024-02-23 2024-02-23 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
2,249
14.80
US$33,278 		2,249 14.80 US$33,278
2024-02-23 2024-02-23 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer

Officer
5,378
14.85
US$79,853 		5,378 14.85 US$79,853
2023-08-09 2023-08-07 S Sale
3.6
REUVERS DANIEL L.

President and CEO

Executive Director
1,062 -0.8%
20.53
US$21,808 		1,062 -0.8% 20.53 US$21,808
2023-08-07 2023-08-07 PrS Proposed sale
3.6
REUVERS DANIEL L.

Officer; Director

Executive Director
1,062
20.53
US$21,808 		1,062 20.53 US$21,808
2023-05-16 2023-05-12 PlS Planned sale
2.6
BURKE WILLIAM W
Non-Executive Director
4,400 -13.7%
21.86
US$96,184 		4,400 -13.7% 21.86 US$96,184
2023-05-12 2023-05-12 PrS Proposed sale
2.6
BURKE WILLIAM W

Director

Non-Executive Director
4,400
21.86
US$96,184 		4,400 21.86 US$96,184
2023-05-10 2023-05-08 PlS Planned sale
3.7
Burns Kristie

Sr. VP Mktg & Clinical Affairs

Officer
786 -2.1%
18.65
US$14,659 		786 -2.1% 18.65 US$14,659
2023-05-10 2023-05-08 PlS Planned sale
2.0
PAULS ERIC

Senior VP, Sales

Officer
550 -1.8%
18.55
US$10,200 		550 -1.8% 18.55 US$10,200
2023-05-08 2023-05-08 PrS Proposed sale
3.7
Burns Kristie

Officer

Officer
786
18.65
US$14,659 		786 18.65 US$14,659
2023-05-08 2023-05-08 PrS Proposed sale
2.0
PAULS ERIC

Officer

Officer
550
18.55
US$10,200 		550 18.55 US$10,200
Explore more

More insider trading research around Tactile Systems Technology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America